Your browser doesn't support javascript.
loading
Q39, a quinoxaline 1,4-Di-N-oxide derivative, inhibits hypoxia-inducible factor-1α expression and the Akt/mTOR/4E-BP1 signaling pathway in human hepatoma cells.
Weng, Qinjie; Zhang, Jun; Cao, Ji; Xia, Qing; Wang, Duoduo; Hu, Yongzhou; Sheng, Rong; Wu, Honghai; Zhu, Difeng; Zhu, Hong; He, Qiaojun; Yang, Bo.
Afiliação
  • Weng Q; Institute of Pharmacology and Toxicology, School of Pharmaceutical Sciences, Zhejiang University, 388# Yuhangtang Rd., Hangzhou, Zhejiang, 310058, China.
Invest New Drugs ; 29(6): 1177-87, 2011 Dec.
Article em En | MEDLINE | ID: mdl-20524035

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Quinoxalinas / Carcinoma Hepatocelular / Neoplasias Hepáticas Experimentais / Antineoplásicos Limite: Animals / Humans / Male Idioma: En Ano de publicação: 2011 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Quinoxalinas / Carcinoma Hepatocelular / Neoplasias Hepáticas Experimentais / Antineoplásicos Limite: Animals / Humans / Male Idioma: En Ano de publicação: 2011 Tipo de documento: Article